Results 101 to 110 of about 480,991 (213)

Chronic Hepatitis B Virus Infection Acquired Under Cytostatic Treatment in Childhood — Clinical, Virological and Immunological Long‐Term Follow‐Up

open access: yesJournal of Viral Hepatitis, Volume 33, Issue 1, January 2026.
ABSTRACT Oncology patients receiving cytostatic therapy used to be at high risk of HBV infection when HBV screening measures were less reliable. Infections acquired under these conditions often persist, like those acquired perinatally or during early infancy.
Thomas Baumgarten   +10 more
wiley   +1 more source

Treatment of Hereditary Angioedema With Plasma‐Derived C1 Inhibitor: A Review

open access: yesClinical and Translational Allergy, Volume 15, Issue 12, December 2025.
ABSTRACT Hereditary angioedema (HAE) is clinically characterized by recurrent episodes of localized edema. HAE typically occurs due to a deficiency of functional C1 inhibitor (C1INH, HAE‐C1INH); in addition, several types of HAE with normal quantity and activity of C1INH (HAE‐nC1INH) have recently been classified, which occur due to different gene ...
Inmaculada Martinez‐Saguer   +3 more
wiley   +1 more source

Persistence and Organ Tropism of Filoviruses in Farmed European Perch (Perca fluviatilis)

open access: yes
Journal of Fish Diseases, EarlyView.
Johanna Perschthaler   +4 more
wiley   +1 more source

How Rwanda mounted a research response with an investigational vaccine just ten days into a Marburg outbreak

open access: yesnpj Vaccines
The September 2024 outbreak of Marburg virus disease (MVD) represented the first time this virus was identified in Rwanda. Health authorities mounted a rapid and effective response, including the rapid execution of an open-label Phase 2 clinical trial of
Sabin Nsanzimana   +18 more
doaj   +1 more source

Marburg virus disease in Equatorial Guinea: The need for one health approach

open access: gold, 2023
Gilbert Eshun   +11 more
openalex   +1 more source

Clinical, Histopathologic, and Immunohistochemical Characterization of Experimental Marburg Virus Infection in A Natural Reservoir Host, the Egyptian Rousette Bat (Rousettus aegyptiacus)

open access: yesViruses, 2019
Egyptian rousette bats (Rousettus aegyptiacus) are natural reservoir hosts of Marburg virus (MARV), and Ravn virus (RAVV; collectively called marburgviruses) and have been linked to human cases of Marburg virus disease (MVD). We investigated the clinical
Megan E.B. Jones   +10 more
doaj   +1 more source

Postexposure Treatment of Marburg Virus Infection

open access: yesEmerging Infectious Diseases, 2010
Rhesus monkeys are protected from disease when a recombinant vesicular stomatitis virus–based vaccine is administered 20–30 min after infection with Marburg virus.
Thomas W. Geisbert   +6 more
doaj   +1 more source

Asymptomatic Infection of Marburg Virus Reservoir Bats Is Explained by a Strategy of Immunoprotective Disease Tolerance [PDF]

open access: bronze, 2020
Jonathan C. Guito   +14 more
openalex   +1 more source

Evaluation of long-term immunity following inoculation with highly diverse orthomarburgvirus isolates in Egyptian rousette bats (Rousettus aegyptiacus)

open access: yesJournal of Virology
Viral coinfections and their impact on long-term immunity represent an understudied area in disease ecology and infectious disease research. Coinfections can influence the host’s susceptibility to future infections, alter host and pathogen population ...
Jessica A. Elbert   +7 more
doaj   +1 more source

Transcriptomics of Marburg virus-infected primary proximal tubular cells reveals negative correlation of immune response and energy metabolism

open access: yesVirus Research
Marburg virus, a member of the Filoviridae, is the causative agent of Marburg virus disease (MVD), a hemorrhagic fever with a case fatality rate of up to 90 %.
Benjamin Koch   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy